iodine has been researched along with Multiple Myeloma in 6 studies
Iodine: A nonmetallic element of the halogen group that is represented by the atomic symbol I, atomic number 53, and atomic weight of 126.90. It is a nutritionally essential element, especially important in thyroid hormone synthesis. In solution, it has anti-infective properties and is used topically.
diiodine : Molecule comprising two covalently bonded iodine atoms with overall zero charge..
Multiple Myeloma: A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Many radiologists and clinicians still consider multiple myeloma (MM) and monoclonal gammopathies (MG) a contraindication for using iodine-based contrast media." | 8.98 | Iodine-based contrast media, multiple myeloma and monoclonal gammopathies: literature review and ESUR Contrast Media Safety Committee guidelines. ( Bellin, MF; Bertolotto, M; Bongartz, G; Clement, O; Heinz-Peer, G; Pozzato, G; Reimer, P; Stacul, F; Thomsen, HS; Ugolini, D; van der Molen, A; Webb, JAW, 2018) |
| "Many radiologists and clinicians still consider multiple myeloma (MM) and monoclonal gammopathies (MG) a contraindication for using iodine-based contrast media." | 4.98 | Iodine-based contrast media, multiple myeloma and monoclonal gammopathies: literature review and ESUR Contrast Media Safety Committee guidelines. ( Bellin, MF; Bertolotto, M; Bongartz, G; Clement, O; Heinz-Peer, G; Pozzato, G; Reimer, P; Stacul, F; Thomsen, HS; Ugolini, D; van der Molen, A; Webb, JAW, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (83.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Stacul, F | 1 |
| Bertolotto, M | 1 |
| Thomsen, HS | 1 |
| Pozzato, G | 1 |
| Ugolini, D | 1 |
| Bellin, MF | 1 |
| Bongartz, G | 1 |
| Clement, O | 1 |
| Heinz-Peer, G | 1 |
| van der Molen, A | 1 |
| Reimer, P | 1 |
| Webb, JAW | 1 |
| KRISS, JP | 1 |
| BIERMAN, HR | 1 |
| THOMAS, SF | 1 |
| NEWELL, RR | 1 |
| KAY, HE | 1 |
| LEDLIE, EM | 1 |
| SBRESNI, RC | 1 |
| Chavaz, A | 1 |
| Mignon, F | 1 |
| Kanfer, A | 1 |
| Richet, G | 1 |
| Spiegelberg, HL | 1 |
| Prahl, JW | 1 |
| Grey, HM | 1 |
| Dérot, M | 1 |
| Wajcner, G | 1 |
| Petrover, M | 1 |
1 review available for iodine and Multiple Myeloma
| Article | Year |
|---|---|
Iodine-based contrast media, multiple myeloma and monoclonal gammopathies: literature review and ESUR Contrast Media Safety Committee guidelines.
Topics: Acute Kidney Injury; Contrast Media; Europe; Humans; Incidence; Iodine; Multiple Myeloma; Paraprotei | 2018 |
5 other studies available for iodine and Multiple Myeloma
| Article | Year |
|---|---|
Treatment of multiple myeloma with radioactive iodine and radioactive iodinated serum albumin.
Topics: Cell- and Tissue-Based Therapy; Humans; Iodine; Iodine Radioisotopes; Multiple Myeloma; Plasma Cells | 1955 |
Treatment of multiple myelomatosis with particular reference to radioactive iodine. Report of five cases.
Topics: Humans; Iodine; Iodine Radioisotopes; Multiple Myeloma; Plasma Cells; Radioisotopes | 1959 |
[Treatment of kidney failure in multiple myeloma by chronic hemodialysis. Apropos of 4 cases].
Topics: Adult; Bone Neoplasms; Contrast Media; Dehydration; Female; Humans; Iodine; Kidney Failure, Chronic; | 1976 |
Structural studies of human gamma D myeloma protein.
Topics: Amino Acids; Autoanalysis; Carbohydrates; Chemical Phenomena; Chemistry; Cyanides; Electrophoresis; | 1970 |
[Acute renal failure in Kahler's disease].
Topics: Acute Kidney Injury; Anuria; Bence Jones Protein; Bicarbonates; Dehydration; Edema; Humans; Injectio | 1969 |